Contractile arrest reveals calcium-dependent stimulation of SERCA2a mRNA expression in cultured ventricular

Ronald Vlasblom1, Alice Muller, René J P Musters

  • 1Laboratory for Physiology, Institute for Cardiovascular Research (ICaR-VU), VU University Medical Center, Van der Boechorststraat 7, 1081 BT Amsterdam, The Netherlands.

Abstract

Insights

Contractile activity in cardiomyocytes opposes sarco-endoplasmic reticulum calcium ATPase 2a (SERCA2a) mRNA upregulation. Calcium signaling pathways involving calcineurin (CN) and calmodulin-dependent protein kinase-II (CAMK-II) promote SERCA2a expression.

Area of Science:

  • Cardiovascular Biology
  • Molecular Cardiology
  • Cellular Physiology

Background:

  • Sarco-endoplasmic reticulum calcium ATPase 2a (SERCA2a) expression is crucial for cardiac function and its downregulation is linked to pathological myocardial hypertrophy.
  • The precise mechanisms by which calcium-dependent signaling and contractile activity regulate myocardial SERCA2a expression are not fully understood.

Purpose of the Study:

  • To investigate the distinct roles of calcium-dependent signaling pathways (calcineurin [CN] and calmodulin-dependent protein kinase-II [CAMK-II]) and contractile activity in regulating myocardial SERCA2a expression.
  • To dissociate the effects of calcium fluxes from mechanical contraction in cardiomyocytes.

Main Methods:

  • Utilized rat neonatal ventricular cardiomyocytes (NVCM) with and without contractile activity (induced by 2,3-butanedione monoxime [BDM]).
  • Analyzed SERCA2a mRNA expression via Northern hybridization following treatment with pharmacological inhibitors of L-type Ca2+-channels (verapamil), CN (cyclosporin A; CsA), and CAMK-II (KN-93).
  • Assessed nuclear translocation of the CN-dependent transcription factor NFATc and evaluated SERCA2a promoter activity using transfection assays with NFATc4 and myocyte enhancer factor 2c (MEF2c).

Main Results:

  • Contractile arrest with BDM significantly increased SERCA2a mRNA levels (2.5-fold), an effect diminished by CsA and KN-93, and abolished by verapamil.
  • NFAT nuclear translocation remained unchanged between control and BDM-treated NVCM.
  • Co-transfection of NFATc4 and MEF2c synergistically stimulated SERCA2a promoter activity.

Conclusions:

  • Calcium-dependent signaling, mediated by CN and CAMK-II, upregulates SERCA2a mRNA expression, likely through synergistic action of NFATc4 and MEF2c on the SERCA2a promoter.
  • Active contractile activity in cardiomyocytes exerts an independent inhibitory effect on SERCA2a mRNA expression.